{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:59:24Z","timestamp":1781643564242,"version":"3.54.5"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hyperinflammation ranges from monophasic to rapidly progressive, life-threatening courses. Early biomarkers to identify high-risk children are needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center cohort included consecutive children with hyperinflammation between 01\/2021 and 01\/2024. Demographic, clinical, laboratory, cardiac imaging, and treatment data were analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 80 patients, 56 (70%) had a recalcitrant course. Fever was universal. Rash, mucosal involvement, and conjunctivitis were more common in the monophasic group, while abdominal pain, neurological signs, pleural effusion, lymphopenia, thrombocytopenia, hypoalbuminemia, and elevated ferritin characterised the recalcitrant group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). Myocarditis and reduced ejection fraction occurred only in the recalcitrant cohort; coronary artery changes were more frequent in monophasic cases (21% vs. 5%). All survived. All received IVIG; steroids and anakinra were used only in recalcitrant cases, who also had longer hospital stays, ICU admissions (21% vs. 0%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01), and required inotropes\/ventilation. Baseline SAA, IL-2R, and NT-proBNP were significantly higher in the recalcitrant cohort. In ROC analyses, NT-proBNP showed the highest diagnostic accuracy (AUC 0.912), followed by IL-2R (AUC 0.873) and SAA (AUC 0.793) (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>NT-proBNP, IL-2R, and SAA were strongly associated with a recalcitrant hyperinflammatory course and may aid early prognostication and monitoring.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12969-026-01206-7","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T15:53:21Z","timestamp":1774367601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting recalcitrant hyperinflammatory disease course in children with Kawasaki disease and MIS-C"],"prefix":"10.1186","volume":"24","author":[{"given":"\u00d6zlem","family":"Satirer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fehime Kara","family":"Eroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Nordmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kumpf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Neunhoeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanya","family":"Icheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Reiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oana","family":"Buzoianu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne M.","family":"Benseler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin B.","family":"Kuemmerle-Deschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"issue":"4","key":"1206_CR1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa2021756","volume":"383","author":"EM Dufort","year":"2020","unstructured":"Dufort EM, et al. Multisystem inflammatory syndrome in children in new york state. N Engl J Med. 2020;383(4):347\u201358.","journal-title":"N Engl J Med"},{"issue":"11","key":"1206_CR2","doi-asserted-by":"publisher","first-page":"e276","DOI":"10.1016\/S1473-3099(20)30651-4","volume":"20","author":"L Jiang","year":"2020","unstructured":"Jiang L, et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis. 2020;20(11):e276\u201388.","journal-title":"Lancet Infect Dis"},{"issue":"40","key":"1206_CR3","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.15585\/mmwr.mm6940e1","volume":"69","author":"SB Morris","year":"2020","unstructured":"Morris SB, et al. Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection - United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep. 2020;69(40):1450\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10239","key":"1206_CR4","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","volume":"395","author":"L Verdoni","year":"2020","unstructured":"Verdoni L, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771\u20138.","journal-title":"Lancet"},{"issue":"10","key":"1206_CR5","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41584-022-00820-5","volume":"18","author":"P Tsoukas","year":"2022","unstructured":"Tsoukas P, Yeung RSM. Kawasaki disease and MIS-C share a host immune response. Nat Rev Rheumatol. 2022;18(10):555\u20136.","journal-title":"Nat Rev Rheumatol"},{"key":"1206_CR6","doi-asserted-by":"publisher","first-page":"103265","DOI":"10.1016\/j.jaut.2024.103265","volume":"147","author":"R Caorsi","year":"2024","unstructured":"Caorsi R, et al. The HyperPed-COVID international registry: impact of age of onset, disease presentation and geographical distribution on the final outcome of MIS-C. J Autoimmun. 2024;147:103265.","journal-title":"J Autoimmun"},{"issue":"1","key":"1206_CR7","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1038\/s41467-022-30357-w","volume":"13","author":"P Ghosh","year":"2022","unstructured":"Ghosh P, et al. An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease. Nat Commun. 2022;13(1):2687.","journal-title":"Nat Commun"},{"issue":"6","key":"1206_CR8","first-page":"815","volume":"39","author":"MD Fridman","year":"2023","unstructured":"Fridman MD, et al. Differentiation of COVID-19-associated multisystem inflammatory syndrome from Kawasaki disease with the use of cardiac biomarkers. Can J Cardiol. 2023;39(6):815\u201323.","journal-title":"Can J Cardiol"},{"issue":"9","key":"1206_CR9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3345\/cep.2021.01459","volume":"65","author":"SH Kim","year":"2022","unstructured":"Kim SH. Diagnosis of coronary artery abnormalities in Kawasaki disease: recent guidelines and z score systems. Clin Exp Pediatr. 2022;65(9):430\u20138.","journal-title":"Clin Exp Pediatr"},{"key":"1206_CR10","unstructured":"2020, W. https:\/\/www.who.int\/news-room\/commentaries\/detail\/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19. 2020."},{"issue":"17","key":"1206_CR11","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the american heart association. Circulation. 2017;135(17):e927\u201399.","journal-title":"Circulation"},{"issue":"8","key":"1206_CR12","first-page":"577","volume":"66","author":"KA Morishita","year":"2020","unstructured":"Morishita KA, Goldman RD. Kawasaki disease recognition and treatment. Can Fam Physician. 2020;66(8):577\u20139.","journal-title":"Can Fam Physician"},{"issue":"3","key":"1206_CR13","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.rdc.2023.03.002","volume":"49","author":"M Noval Rivas","year":"2023","unstructured":"Noval Rivas M, Arditi M. Kawasaki disease and multisystem inflammatory syndrome in children: common inflammatory pathways of two distinct diseases. Rheum Dis Clin North Am. 2023;49(3):647\u201359.","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"1206_CR14","first-page":"73","volume":"40","author":"ED Batu","year":"2024","unstructured":"Batu ED. Multisystem inflammatory syndrome in children vs Kawasaki disease: a never-ending spectrum of phenotypes. Can J Cardiol. 2024;40(1):73\u20136.","journal-title":"Can J Cardiol"},{"issue":"4","key":"1206_CR15","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.cell.2020.09.016","volume":"183","author":"CR Consiglio","year":"2020","unstructured":"Consiglio CR, et al. The Immunology of multisystem inflammatory syndrome in children with COVID-19. Cell. 2020;183(4):968\u2013e9817.","journal-title":"Cell"},{"issue":"1","key":"1206_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12969-022-00771-x","volume":"20","author":"T Tong","year":"2022","unstructured":"Tong T, et al. Similarities and differences between MIS-C and KD: a systematic review and meta-analysis. Pediatr Rheumatol Online J. 2022;20(1):112.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"1206_CR17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2217\/bmm-2020-0669","volume":"15","author":"DG McKechnie","year":"2021","unstructured":"McKechnie DG, et al. Inflammatory markers and incident heart failure in older men: the role of NT-proBNP. Biomark Med. 2021;15(6):413\u201325.","journal-title":"Biomark Med"},{"key":"1206_CR18","doi-asserted-by":"crossref","unstructured":"Farooqi KM, et al. Longitudinal outcomes for multisystem inflammatory syndrome in children. Pediatrics. 2021;148(2).","DOI":"10.1542\/peds.2021-051155"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-026-01206-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-026-01206-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-026-01206-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:47:51Z","timestamp":1781642871000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12969-026-01206-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1206"],"URL":"https:\/\/doi.org\/10.1186\/s12969-026-01206-7","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Ethics Committee of the Medical Faculty at Eberhard Karls University and the University Hospital Tuebingen (Project No: 782\/2023BO2). The study was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from the patient(s) and\/or their legal guardians for participation in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}